AVANIR PHARMACEUTICALS INC CLA
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for AVANIR PHARMACEUTICALS INC CLA COM, CUSIP 053994703.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for AVANIR PHARMACEUTICALS INC CLA COM, CUSIP 053994703.